Medicine and Dentistry
Hypertrophic Cardiomyopathy
100%
Myocardial Disease
59%
Hypertrophic Obstructive Cardiomyopathy
41%
Cardiac Magnetic Resonance Imaging
28%
Diseases
24%
Congestive Heart Failure
23%
Sudden Cardiac Death
19%
Placebo
16%
Sarcomere
14%
Dilated Cardiomyopathy
14%
Heart Ventricle Arrhythmia
13%
Obstruction
12%
Left Ventricular Hypertrophy
12%
Implantable Automatic Defibrillator
11%
Prevalence
11%
Hazard Ratio
11%
Quality of Life
11%
Heart Left Ventricle Ejection Fraction
10%
Biological Marker
10%
New York Heart Association Class
9%
Health Care Cost
9%
Risk Stratification
9%
Bone Scintigraphy
9%
Muscle Resection
8%
Cardiac Dysrhythmia
8%
Faintness
8%
Adverse Outcome
7%
Cardiology
7%
Genetic Screening
7%
Echocardiography
7%
Clinical Trial
7%
ATTR Amyloidosis
7%
Transthyretin
7%
Ventricular Outflow Tract
7%
Noncompaction Cardiomyopathy
6%
Systematic Review
6%
Atrial Fibrillation
6%
Amyloidosis
5%
Cohort Analysis
5%
Pathophysiology
5%
Electrocardiogram
5%
Gadolinium
5%
Apoplexy
5%
Transthoracic Echocardiography
5%
Primary Prevention
5%
Biochemistry, Genetics and Molecular Biology
Genotyping
36%
Genetics
31%
Cardiac Dysrhythmia
22%
Sudden Cardiac Death
19%
Cardiac Muscle Cell
17%
Prevalence
14%
Genetic Screening
13%
Tubulin
10%
Magnetic Resonance Imaging
9%
Missense
9%
Disease Burden
9%
Cohort Study
9%
Implantable Cardioverter-Defibrillator
9%
Heart Left Ventricle Ejection Fraction
8%
Ventricular Tachycardia
8%
Clinical Trial
8%
Proteomics
7%
Atrial Fibrillation
6%
Troponin T
6%
Polygenic Score
6%
Filamin
6%
Penetrance
6%
Genome-Wide Association Study
6%
Energy Transfer
5%
Transcription Factors
5%
Mendelian Randomization
5%
Heart Left Ventricle Contractility
5%
MYH7
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertrophic Cardiomyopathy
61%
Hypertrophic Obstructive Cardiomyopathy
31%
Myocardial Disease
26%
Congestive Heart Failure
20%
Diseases
17%
Placebo
12%
Obstruction
12%
Biological Marker
12%
Sudden Cardiac Death
11%
Heart Left Ventricle Hypertrophy
8%
Faintness
8%
Heart Ventricle Arrhythmia
8%
Heart Ventricle Tachycardia
8%
Congestive Cardiomyopathy
8%
Heart Arrhythmia
8%
Cohort Study
7%
Transthyretin
6%
Adverse Outcome
6%
Mavacamten
6%
Atrial Fibrillation
6%
Cerebrovascular Accident
6%
Heart Disease
6%
